test

Wajih Zaheer MD, FACP

Assistant Clinical Professor of Medicine; Asstt Clinical Professor Of Medicine (Medical Oncology)

Clinical Interests

solid tumor malignancies, particularly breast, lung, and gastrointestinal cancers/pancreatic cancer ; hematologic malignancies such as lymphoma, leukemia, and myeloproliferative disorders. Genitourinary malignancies.


Board Certifications

1991
Internal Medicine, Board Certified
1995
Medical Oncology, Board Certified
1996
Hematology (Internal Medicine), Board Certified

Patient Care Locations

wajih_zaheerfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Colorectal Cancer and ColonC80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Breast - FemaleA Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less (SWOG S1007) (CIRB)
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Cancer, Breast - Female, and Breast - MalePhase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer (S1207)
Breast - Female and Breast - MaleRandomized Phase II trial of Neoadjuvant Cisplatin vs. Doxorubicin/Cyclophosphamide (AC) in Women with Newly Diagnosed Breast Cancer and Germline BRCA Mutations

More Clinical Trials...

Edit Profile